Microbiomics research is progressing at a rapid rate as we get a better understanding of the impact of the microbiome on our bodies via Eagle Genomics
Current and future advancements will have a profound socioeconomic impact globally. Eagle Genomics is actively engaged with global companies in their microbiomic R&D programmes. Our mixed expertise in biology, bioinformatics and knowledge management coupled with our powerful software platform has already transformed new product innovation in the microbiomic sector.
Market Impact of Microbiomics Analysis
- Global Human Microbiome Market expected to grow 21.9% by 2022, to $521.23m
- Pre & Probiotic foods and supplements worth $19bnglobally
- Global Market for animal feed additives $10.6bn
- Medical Foods & Drinks worth$9bn globally
- $801m expected turnover in Therapeutics by 2023
- Global Nutraceutical Market worth $207bn